Skip to content
Paushak logo

Paushak

PAUSHAKLTD NSE
₹607.05 down 6.00 (0.98%)
Market Cap
₹1,497 Cr
P/E
31.67

Paushak (PAUSHAKLTD) share price was ₹613.05 at the 28 Oct 2026 close; market capitalisation ₹1,512 Cr; P/E (TTM) 31.98; sector Chemicals. The share price fell 12.1% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Sep 2026 quarter, revenue rose 51.9% year on year to ₹89.3 Cr and net profit was ₹14 Cr, against ₹9 Cr a year earlier (compared with Sep 2025). Promoters held 67.28% of Paushak in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 56/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹613.05 −70.95 −10.37% 1Y

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals
Market Cap
₹1,497 Cr
P/E (TTM)
31.67
EBITDA
₹72.90 Cr
Return on Equity
8.01%
Debt to Equity
0.16
Book Value
₹209.51
EPS (TTM)
₹19.17
52W High
₹881.95
52W Low
₹342.50

Price-based figures as of 29 Oct 2026, 10:47 IST · EPS basis: Standalone · TTM

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Pidilite Industries
₹1,368.1052.581,39,256 Cr12.861.48%22.36%28.48%15,689 Cr2,677 Cr
Gujarat Fluorochemicals
₹4,248.0077.1246,664 Cr5.970.07%7.25%10.13%5,334 Cr600 Cr
Navin Fluorine International
₹8,359.5054.2642,878 Cr10.790.18%16.70%18.66%3,734 Cr789 Cr
Aether Industries
₹1,578.2089.0120,947 Cr8.530.00%8.94%12.15%1,257 Cr235 Cr
Deepak Nitrite
₹1,487.0025.8920,282 Cr3.470.52%9.38%10.85%8,624 Cr784 Cr
Aarti Industries
₹462.5531.5916,772 Cr2.820.23%7.04%8.53%9,040 Cr531 Cr
Atul
₹5,154.5019.6615,176 Cr2.310.55%10.95%13.54%7,185 Cr788 Cr
Paushak (this company)
₹607.0531.671,497 Cr2.900.40%8.01%8.67%291 Cr48 Cr
Median 8 companies₹1,532.6042.1320,614 Cr4.720.32%9.16%11.50%6,260 Cr692 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

56 Good
Overall score

Data confidence 100/100

surveillance:ASM1

Category scores

Quality Average 50
Returns, margins, earnings quality 22% weight
Valuation Poor 29
Cheap vs sector & own history 24% weight
Growth Strong 86
Sales & profit trajectory 9% weight
Financial Health Strong 73
Solvency, leverage, coverage 9% weight
Momentum Strong 69
Trend strength, vol-adjusted 12% weight
Ownership Strong 76
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is expected to give good quarter

Weaknesses

4
  • Stock is trading at 3.15 times its book value
  • The company has delivered a poor sales growth of 9.17% over past five years.
  • Company has a low return on equity of 9.58% over last 3 years.
  • Dividend payout has been low at 13.2% of profits over last 3 years

Technical Indicators

Oscillators

Bullish

Bearish
2
Neutral
4
Bullish
3

Overall

Bearish

Bearish
11
Neutral
4
Bullish
4

Moving Averages

Bearish

Bearish
9
Neutral
0
Bullish
1

Growth Rate

Revenue Growth
2.44% higher than 3Y

change over 1 year

Net Income Growth
-20.45% lower than 3Y

change over 1 year

Cash Flow Change
42.72%

change over 1 year

EBITDA Margin Change
-3.69%

change over 1 year Operating margin 30% · Sep 2026

Quarterly Results

Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
52
52
54
52
57
49
52
56
59
49
55
84
89
Expenses
38
33
35
40
40
35
36
38
44
37
38
58
63
Operating Profit
14
19
19
12
17
15
16
18
15
11
17
26
26
OPM %
28%
36%
35%
23%
30%
30%
30%
32%
25%
23%
30%
31%
30%
Other Income
7
3
7
4
4
6
0
2
1
1
8
3
2
Interest
0
0
0
0
0
0
0
0
0
0
1
1
1
Depreciation
3
3
4
4
4
4
4
4
4
5
8
8
8
PBT
18
18
23
12
17
17
12
16
11
7
16
19
19
Tax %
25%
26%
19%
17%
16%
11%
21%
23%
24%
17%
22%
21%
27%
Net Profit
13
14
18
10
14
15
10
12
9
6
13
15
14
EPS (₹)
5.42
5.54
7.42
4.19
5.77
6.2
3.9
4.89
3.5
2.5
5.07
6.12
5.48
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
69
78
72
105
140
138
141
150
212
206
211
219
277
Expenses
52
61
60
75
99
95
91
96
137
142
151
158
197
Operating Profit
17
17
12
29
40
43
50
54
75
65
60
61
80
OPM %
25%
22%
17%
28%
29%
31%
36%
36%
35%
31%
28%
28%
29%
Other Income
3
3
5
3
13
7
6
5
11
20
14
12
14
Interest
0
0
0
0
0
0
0
0
0
0
0
1
4
Depreciation
2
3
3
3
4
4
5
9
13
14
15
21
30
PBT
18
17
14
29
49
45
52
50
72
71
59
50
61
Tax %
28%
25%
22%
26%
20%
23%
28%
25%
25%
23%
16%
22%
—
Net Profit
13
12
11
21
39
35
37
38
54
54
49
39
47
EPS (₹)
5.07
4.85
4.27
8.39
15.84
14.19
15.16
15.29
21.96
22.09
20.07
15.95
19.17
Div. Payout %
7%
8%
9%
4%
4%
5%
5%
10%
10%
11%
12%
16%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
3
3
3
3
3
3
3
3
3
3
3
12
12
Reserves
54
65
80
110
174
224
269
302
351
405
462
479
504
Borrowings
0
1
0
1
0
0
0
0
0
0
25
77
68
Other Liabilities
11
13
11
31
36
43
57
61
61
73
81
92
100
Total Liabilities
69
82
94
144
214
270
329
367
415
481
572
660
684
Fixed Assets
18
20
35
37
38
41
51
147
149
152
141
377
375
CWIP
1
12
0
1
6
16
68
8
7
29
190
26
16
Investments
19
18
33
53
116
163
154
151
182
223
139
150
168
Other Assets
30
31
26
54
54
50
56
61
78
77
102
107
126
Total Assets
69
82
94
144
214
270
329
367
415
481
572
660
684
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
9
14
12
10
24
41
30
44
43
56
38
54
Investing
-8
-13
-11
-10
0
-39
-29
-42
-38
-50
-57
-95
Financing
-1
-1
-2
-1
-23
-2
-2
-2
-4
-5
19
42
Net Cash Flow
0
0
0
0
0
0
-1
0
0
0
-1
0
Free Cash Flow
0
-3
7
5
13
27
-26
-4
28
17
-122
-34
CFO/EBITDA
77
104
118
56
85
116
85
98
73
107
82
97
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
114
97
83
135
85
69
85
97
90
90
94
92
Inventory Days
96
117
125
118
122
131
148
233
180
177
179
292
Days Payable
94
104
70
170
73
110
118
227
122
130
167
245
Cash Conversion Cycle
116
110
138
83
133
89
115
103
149
137
107
139
Working Capital Days
108
92
92
107
100
75
60
81
93
84
80
64
ROCE %
32%
25%
12%
29%
27%
21%
20%
17%
21%
17%
11%
8%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Paushak insights

63 extracted metrics + investor summaries across FY11–FY27.

Shareholding Pattern

FIIs0.11%Promot.67.28%DIIs0.27%Others10.17%Public22.18%As ofSep 2026

Documents

Frequently Asked Questions about Paushak

What does Paushak Ltd do?
Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907. [1][2]
Where is Paushak Ltd (PAUSHAKLTD) listed?
Paushak Ltd trades as PAUSHAKLTD on the NSE and under code 532742 on the BSE.
Which sector does Paushak Ltd belong to?
Paushak Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Paushak Ltd?
Paushak Ltd has a market capitalisation of ₹1,497 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Paushak Ltd?
Paushak Ltd trades at a PE ratio of 31.67 as of 29 Oct 2026, on earnings per share of ₹19.17, against a book value of ₹209.51 per share.
What is the 52-week high and low of Paushak Ltd?
Over the last 52 weeks Paushak Ltd has traded between ₹342.5 and ₹881.95 as of 29 Oct 2026.
Does Paushak Ltd pay dividends?
Paushak Ltd has a dividend yield of 0.41%.
What is the Return on Equity (ROE) of Paushak Ltd?
Paushak Ltd reported a return on equity of 8.01%. Its debt-to-equity ratio is 0.16.

Company Information

Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907. [1][2]

Website paushak.com
CEO Mr. Chintan Tarunkumar Gosaliya
Employees 380
Listed 2025-12-01
Face Value ₹ 5
Shares Outstanding 2,46,56,912

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PAUSHAKLTD.md for Paushak Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month